Peter Björk
1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
- Exploring novel therapeutic options in T-LGL, including epigenetic modulation: A case report.
- 2009
- Minor stroke as singular manifestation of hereditary thrombotic thrombocytopenic purpura in a young man.
- 2007
-
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.
Manea Hedström, Minola LU ; Kristoffersson, Ann-Charlotte LU ; Tsai, Han-Mou ; Zhou, Wenhua ; Winqvist, Ingemar ; Oldaeus, Goran ; Billstrom, Rolf ; Björk, Peter LU ; Holmberg, Lars LU and Karpman, Diana LU
(2007)
In European Journal of Pediatrics
166(3).
p.249-257
Mark
- Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis
-
Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura
Manea Hedström, Minola LU ; Kristoffersson, Ann-Charlotte LU ; Schneppenheim, Reinhard ; Saleem, Moin A. ; Mathieson, Peter W. ; Mörgelin, Matthias LU ; Björk, Peter LU ; Holmberg, Lars LU and Karpman, Diana LU
(2007)
In British Journal of Haematology
138(5).
p.651-662
Mark
- 2003
- Absorbed Dose Determination and Characteristics of Degraded Electron Beams: Application to Intraoperative Radiation Therapy
- 1997
- The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase
- 1991
- Release of dog polymorphonuclear leukocyte cathepsin g, normally and in endotoxin and pancreatitic shock : Isolation and partial characterization of dog polymorphonuclear leukocyte cathepsin g